These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1831887

  • 1. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists.
    Morris BJ, Hunt SP.
    Neurosci Lett; 1991 Apr 29; 125(2):201-4. PubMed ID: 1831887
    [Abstract] [Full Text] [Related]

  • 2. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain.
    Angulo JA.
    J Neurochem; 1992 Mar 29; 58(3):1104-9. PubMed ID: 1346626
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist.
    Caboche J, Vernier P, Julien JF, Rogard M, Mallet J, Besson MJ.
    J Neurochem; 1991 Feb 29; 56(2):428-35. PubMed ID: 1824860
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists.
    Morris BJ, Höllt V, Herz A.
    Neuroscience; 1988 May 29; 25(2):525-32. PubMed ID: 3041310
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE, Wooten GF.
    Brain Res Mol Brain Res; 1992 Jan 29; 12(1-3):111-9. PubMed ID: 1312196
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of acute dopaminergic D1 and D2 receptor antagonists on proneurotensin mRNA expression in rat striatum.
    Augood SJ, Kiyama H, Faull RL, Emson PC.
    Brain Res Mol Brain Res; 1991 Mar 29; 9(4):341-6. PubMed ID: 1645436
    [Abstract] [Full Text] [Related]

  • 8. Dopaminergic D1 and D2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum.
    Augood SJ, Kiyama H, Faull RL, Emson PC.
    Neuroscience; 1991 Mar 29; 44(1):35-44. PubMed ID: 1685231
    [Abstract] [Full Text] [Related]

  • 9. Quantitative in situ hybridization evidence for differential regulation of proenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine.
    Cadet JL, Zhu SM, Angulo JA.
    Brain Res Mol Brain Res; 1992 Jan 29; 12(1-3):59-67. PubMed ID: 1312206
    [Abstract] [Full Text] [Related]

  • 10. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA, Mansour A, Watson SJ.
    Exp Neurol; 1994 Dec 29; 130(2):288-303. PubMed ID: 7867758
    [Abstract] [Full Text] [Related]

  • 11. Reduction of dopamine receptor activity differentially alters striatal neuropeptide mRNA levels.
    Angulo JA, Christoph GR, Manning RW, Burkhart BA, Davis LG.
    Adv Exp Med Biol; 1987 Dec 29; 221():385-91. PubMed ID: 3434462
    [Abstract] [Full Text] [Related]

  • 12. Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence.
    Svensson P, Hurd YL.
    Brain Res Mol Brain Res; 1998 May 29; 56(1-2):162-8. PubMed ID: 9602109
    [Abstract] [Full Text] [Related]

  • 13. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M, Grondin R, Goulet M, Bédard PJ, Di Paolo T.
    J Neurochem; 1999 Feb 29; 72(2):682-92. PubMed ID: 9930741
    [Abstract] [Full Text] [Related]

  • 14. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A, Yamaguchi T, Kato T.
    Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213
    [Abstract] [Full Text] [Related]

  • 15. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine.
    Wang JQ, McGinty JF.
    Synapse; 1996 Feb 04; 22(2):114-22. PubMed ID: 8787127
    [Abstract] [Full Text] [Related]

  • 16. D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons.
    Pollack AE, Wooten GF.
    Brain Res Mol Brain Res; 1992 Mar 04; 13(1-2):35-41. PubMed ID: 1315917
    [Abstract] [Full Text] [Related]

  • 17. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF, Sanberg PR, Norman AB.
    Brain Res; 1988 May 31; 450(1-2):403-7. PubMed ID: 2969764
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum.
    Laprade N, Soghomonian JJ.
    Brain Res Mol Brain Res; 1995 Dec 01; 34(1):65-74. PubMed ID: 8750862
    [Abstract] [Full Text] [Related]

  • 19. Increased proenkephalin mRNA levels in the rat neostriatum following lesion of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): reversal by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ, Dunnett SB.
    Brain Res Mol Brain Res; 1991 Feb 01; 9(3):263-9. PubMed ID: 1851529
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptor-mediated mechanisms involved in the expression of learned activity of primate striatal neurons.
    Watanabe K, Kimura M.
    J Neurophysiol; 1998 May 01; 79(5):2568-80. PubMed ID: 9582229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.